# Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers

> **NCT01527734** · PHASE1 · COMPLETED · sponsor: **Wex Pharmaceuticals Inc.** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Tetrodotoxin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01527734
- **Lead sponsor:** Wex Pharmaceuticals Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-01
- **Final completion:** —
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2012-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527734

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527734, "Comparison Study of Liquid and Lyophilized Formulations of Subcutaneous Tetrodotoxin (TTX) in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01527734. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*